XML 102 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Amounts related to cumulative basis adjustments for fair value hedges
At March 31, 2024 and December 31, 2023, the following amounts were recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:
(Dollars in millions)March 31,
2024
December 31,
2023
Short-term debt:  
Carrying amount of the hedged item$— $(1)
Cumulative hedging adjustments included in the carrying amount — assets/(liabilities) (1)
$— $(1)
Long-term debt:  
Carrying amount of the hedged item$(6,499)$(6,629)
Cumulative hedging adjustments included in the carrying amount — assets/(liabilities) (1)
$191 $61 
(1)Includes ($188) million and ($200) million of hedging adjustments on discontinued hedging relationships at March 31, 2024 and December 31, 2023, respectively.
Effect of derivative instruments in the Consolidated Income Statement
The total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value hedges, cash flow hedges, net investment hedges and derivatives not designated as hedging instruments are recorded and the total effect of hedge activity on these income and expense line items are as follows:
(Dollars in millions)TotalGains/(Losses) of
Total Hedge Activity
For the three months ended March 31:2024202320242023
Cost of services$5,239 $5,310 $$(2)
Cost of sales$1,381 $1,322 $12 $14 
Cost of financing$99 $110 $(3)$(3)
SG&A expense$4,974 $4,853 $74 $59 
Other (income) and expense$(317)$(245)$(287)$142 
Interest expense$432 $367 $(15)$(14)
Gain (Loss) Recognized in Consolidated Income Statement
(Dollars in millions)Consolidated
Income Statement
Line Item
Recognized on
Derivatives
Attributable to Risk
Being Hedged (2)
For the three months ended March 31:2024202320242023
Derivative instruments in fair value hedges: (1)
     
Interest rate contractsCost of financing$(27)$13 $22 $(17)
Interest expense(138)53 110 (68)
Derivative instruments not designated as hedging instruments: 
Foreign exchange contractsOther (income) and expense(207)16  N/A  N/A
Equity contractsSG&A expense71 49  N/A  N/A
Total $(302)$131 $131 $(84)
Gain (Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income
Recognized in OCIConsolidated
Income Statement
Line Item
Reclassified
from AOCI
Amounts Excluded from
Effectiveness Testing (3)
(Dollars in millions)
For the three months ended March 31:202420232024202320242023
Derivative instruments in cash flow hedges:       
Interest rate contracts$— $— Cost of financing$(1)$(1)$— $— 
Interest expense(4)(3)— — 
Foreign exchange contractsCost of services(2)— — 
Amount included in the assessment of effectiveness166 (29)Cost of sales12 14 — — 
Amount excluded from the assessment of effectiveness10 — Cost of financing(1)(4)— — 
SG&A expense10 — — 
Other (income) and expense(61)126 (18)— 
Interest expense(5)(17)— — 
Instruments in net investment hedges: (4)
       
Foreign exchange contracts612 (224)Cost of financing— — 
  Interest expense— — 22 22 
Total$787 $(253) $(52)$122 $$28 
(1)The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.
(2)The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.
(3)The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing for net investment hedges in net income each period. For cash flow hedges of foreign currency denominated debt, the amounts excluded from effectiveness testing are amortized to net income over the life of the hedging instrument.
(4)Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.
N/A - not applicable